![overlay-bottom[1]](https://ambrygen.com/wp-content/uploads/2026/02/overlay-bottom1.svg)
Articles Tagged: Hereditary Cancer
December 5, 2023
Addressing equity in exome sequencing: Proactive reanalysis through the Ambry Patient for Life program helps to reduce racial, ethnic, and ancestral disparities
Emerging evidence shows that exome sequencing outcomes can see similar racial and ethnic disparities as other genetic tests. Therefore, exome reanalysis represents a step to…
Genetic Discrimination
Hereditary Cancer
Whole Exome Sequencing
September 14, 2023
Ovarian Cancer Awareness Month Spotlight: Norma Livingston Ovarian Cancer Foundation
The Norma Livingston Ovarian Cancer Foundation (NLOCF) was founded in Birmingham, Alabama in 2004. For Ovarian Cancer Awareness month, Ambry explores its history, spotlights campaigns…
Advocacy Group
Awareness
Genetic Counselors
Genetic Testing
Hereditary Cancer
Ovarian Cancer
January 4, 2019
3 Common Questions from Healthcare Providers about Genetic Testing
Here we are answering 3 common questions about genetic testing for hereditary breast cancer: Learn more today
Hereditary Cancer
Questions
May 15, 2018
Increase the Detection of Patients with Hereditary Cancer
Identifying patients with hereditary cancer is critical so that you can provide risk counseling and management planning.
Hereditary Cancer
December 6, 2017
How Ambry Affected Hereditary Cancer Testing in 2017
Looking back on 2017, here are some of Ambry’s accomplishments in the area of oncology testing
Community Outreach
end of year 2017
Genetic Testing
Hereditary Cancer
October 4, 2017
Hereditary Cancer Tests: Is Bigger Always Better?
Just five short years ago, hereditary cancer testing was much simpler for patients and healthcare providers. There were finite criteria, associated with a handful of…
Genetic Testing
Hereditary Cancer
